Virus-specific antibody titres in different phases of hepatitis C virus infection

Journal of Viral Hepatitis

Volumn 9, Issue 6, 2002, Pages 429-437

  Nikolaeva, L I ^a,e   Blokhina, N P ^b   Tsurikova, N N ^b   Voronkova, N V ^b   Miminoshvili, M I ^c   Braginsky, D M ^c   Yastrebova, O N ^d   Booynitskaya, O B ^b   Isaeva, O V ^a   Michailov, M I ^a   Archakov, A I ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b 2nd Hospital of Infection Diseases   (Russian Federation)

^c D I IVANOVSKY INSTITUTE OF VIROLOGY   (Russian Federation)

^d Vektor Best Company   (Russian Federation)

^e INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

C virus; Hepatitis antibody titre; Phases of the infection

Indexed keywords

ALPHA INTERFERON; ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PROTEIN;

ACUTE DISEASE; ADULT; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CHRONIC DISEASE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; TIME;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CHILD; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATITIS C ANTIGENS; HEPATITIS C, CHRONIC; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERFERON-ALPHA; MALE; MIDDLE AGED;

EID: 18744403673     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.2002.00369.x     Document Type: Article

References (50)

1. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-362.
2. Choo Q-L, Weiner AJ, Overby LR, Kuo G, Houghton M, Bradley DW. Hepatitis C virus: The major causative agent of viral non-A, non-B viral hepatitis. Br Med Bull 1990; 46: 423-441.
3. Kaito M, Watanabe S, Tsukiyama-Kohara K et al. Hepatitis C virus particle detected by immunoelectron microscopic study. J Gen Virol 1994; 75: 1755-1760.
4. Trestard A, Bacq Y, Buzelay L et al. Ultrastructural and physicochemical characterization of the hepatitis C virus recovered from the serum of an agammaglobulinemic patients. Arch Virol 1998; 143: 2241-2245.
5. Martell M, Esteban JL, Quer J et al. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: Quasispecies nature of HCV genome distribution. J Virol 1992; 66: 3225-3239.
6. Simmonds P, Holmes EC, Cha TA et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993; 74: 2391-2399.
7. Choo Q-L, Richman KH, Han JH et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 1991; 88: 2451-2455.
8. Takamizawa A, Mori C, Fuke I et al. Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol 1991; 65: 1105-1113.
9. Houghton M, Weiner A, Han J, Kuo G, Choo Q-L. Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease. Hepatology 1991; 14: 381-388.
10. Selby MJ, Choo Q-L, Berger K et al. Expression of the proteins encoded by the hepatitis C viral genome. J Gen Virol 1993; 74: 1103-1113.
11. Lanford RE, Notvall L, Chavez D et al. Analysis of hepatitis C virus capsid, E1, and E2/NS1 proteins expressed in insect cells. Virology 1993; 197: 225-235.
12. Ruster B, Zeuzem S, Roth WK. Hepatitis C virus sequences encoding truncated core proteins detected in a hepatocellular carcinoma. Biochem Biophis Res Comm 1996; 219: 911-915.
13. Moriya K, Fujie H, Shintani J et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 1998; 4: 1065-1067.
14. Chen C-M, You L-R, Hwang L-H, Lee Y-H. Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-beta receptor modulates the signal pathway of the lymphotoxin-beta receptor. J Virol 1997; 71: 9417-9426.
15. Shrivastava A, Manna SK, Ray R, Aggarwal BB. Ectopic expression of hepatitis C virus core protein differently regulates nuclear transcription factors. J Virol 1998; 72: 9722-9728.
16. Barba G, Harper F, Harada T et al. Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Pros Natl Acad Sci USA 1997; 94: 1200-1205.
17. Large MK, Kittlesen DJ, Hahn YS. Suppression of host immune response by the core protein of hepatitis C virus: Possible implications for hepatitis C virus persistence. J Immunol 1999; 162: 931-938.
18. Langhans B, Lechmann M, Ihlenfeldt H et al. A hepatitis C virus (HCV) core protein derived peptide inhibits HCV specific lymphocyte proliferation. Eur J Med Res 2000; 5: 115-120.
19. Rosa D, Campagnoli S, Moretto C et al. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: Cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc Natl Acad Sci USA 1996; 93: 1759-1763.
20. Ishii K, Rosa D, Watanabe Y et al. High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C. Hepatology 1998; 28: 1117-1120.
21. Significance of the anti-E2 response in self-limited and chronic hepatitis C virus infections in chimpanzees and in humans. J Infect Dis 1999; 180: 987-991.
22. Grakowi A, McCourt DW, Wychowscki C, Feinstone SM, Rice CM. A second hepatitis C virus-encoded protease. Proc Natl Acad Sci USA 1993; 90: 10583-10587.
23. Hijikata M, Muzyshima H, Acagi T et al. Two distinct pro-teinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J Virol 1993; 67: 4665-4675.
24. Yao N, Hesson T, Cable M et al. Structure of the hepatitis C virus RNA helicase domain. Nat Struct Biol 1997; 4: 463-467.
25. Love RA, Parge HF, Wickersham JA et al. The conformation of hepatitis C virus NS3 proteinase with and without NS4A: A structural basis for the activation of the enzyme by its cofactor. Clin Diagn Virol 1998; 10: 151-156.
26. Behrens SE, Tomei L, Francesco R. Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus. EMBO J 1996; 15: 12-22.
27. Tremolada F, Casarin C, Alberti A et al. Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis. J Hepatol 1992; 16: 273-281.
28. Villano SA, Vlahov D, Nelson KE, Cohn S, Thomas DL. Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology 1999; 29: 908-914.
29. DiBisceglie AM, Googman ZD, Ishak KG et al. Long-term clinical and histopathological follow-up of chronic post-transfusion hepatitis. Hepatology 1991; 14: 969-974.
30. Dhillon AP, Dusheiko GM. Pathology of hepatitis C virus infection. Histopathology 1995; 26: 297-309.
31. Pape GR, Gerlach TJ, Diepolder HM, Gruner N, Jung M, Santantonio T. Role of the specific T-cell response for clearance and control of hepatitis C virus. J Viral Hepat 1999; 6 (Suppl. 1): 36-40.
32. Gruner NH, Gerlach TJ, Jung MC et al. Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C. J Infect Dis 2000; 181: 1528-1536.
33. Lechner F, Wong DK, Dunbar PR et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 2000; 191; 1499-1512.
34. Beld M, Penning M, van Putten M et al. Quantitative antibody responses to structural (core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among serocon-verting injecting drug users: Impact of epitope variation and relationship to detection of HCV RNA in blood. Hepatology 1999; 29: 1288-1298.
35. Bassett SE, Brasky KM, Lanford RE. Analysis of hepatitis C virus-inoculated chimpanzees reveals unexpected clinical profiles. J Virol 1998; 72: 2589-2599.
36. Masyago AV. The state comparative analysis of assays using for diagnostic tests of hepatitis B and C. News Vector-Best 2000; 4: 3-5 [in Russian].
37. Malyshev VS, Karpov VV, Vedyakov AG, Sergeyev YV, Tonevitskjj AG, Karaylov AV. The comparison of antibodies against hepatitis C virus in patients with chronic hepatitis C and HCV-positive donors. Immunology 2001; 3: 51-52 [in Russian].
38. Yastrebova ON. The use of anti-HCV IgM assay for diagnostic test of viral hepatitis C. News Vector-Best 1998; 1: 6-8 [in Russian].
39. Thomas DL, Zenilman JM, Alter HJ et al. Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore: An analysis of 309 sex partnerships. J Infect Dis 1995; 171: 768-775.
40. Giuberti T, Ferrari C, Marchelli S et al. Long-term follow-up of anti-hepatitis C virus antibodies in patients with acute nonA nonB hepatitis and different outcome of liver disease. Liver 1992; 12: 94-99.
41. Yamagushi N, Tokushige K, Yamauchi K, Hayashi N. Humoral immune response in Japanese acute hepatitis patients with hepatitis C virus infection. Can J Gastroenterol 2000; 14: 593-598.
42. Van Der Poel CL, Cuypers HYM, Reesink HW et al. Confir-mation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet 1991; 337: 317-319.
43. McHutchison JG, Person JL, Govindarajan S et al. Improved detection of hepatitis C virus antibodies in high-risk population. Hepatology 1992; 15: 19-25.
44. Chien DY, McFarland J, Tabrizi A, Kuo C, Houghton M, Kuo G. Distinct subtypes of hepatitis C virus defined by antibodies directed to the putative core, NS4, and NS5 region polypeptides. Nishioka, N, Suzuki, S, Mishiro, S, Oda, T, eds. Viral Hepatitis and Liver Disease. Springer-Verlag: Tokyo. 1994; 320-324.
45. Zaaijer HL, Mimms LT, Cuypers HT et al. Variability of IgM response in hepatitis C infection. J Med Virol 1993; 40: 184-187.
46. Quiroga JA, Campillo ML, Catillo I, Bartolome J, Porres JC, Carreno V. IgM antibody to hepatitis C virus in acute and chronic hepatitis C. Hepatology 1991; 14: 38-43.
47. Yuki N, Hayashi N, Ohkawa K et al. The significance of immunoglobulin M antibody response to hepatitis C virus core protein in patients with chronic hepatitis C. Hepatology 1995; 22: 402-406.
48. Chen PJ, Wang JT, Hwang LH et al. Transient immunoglobulin M antibody response to hepatitis C virus capsid antigen in posttransfusion hepatitis C: Putative serological marker for acute viral infection. Proc Natl Acad Sci USA 1992; 89: 5971-5975.
49. Clemens JM, Taskar S, Chau K et al. IgM antibody response in acute hepatitis C infection. Blood 1992; 79: 169-172.
50. Cramp ME, Catucci P, Rossol S et al. Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia. Gut 1999; 44: 424-429.